Xuan Hong Tran is a corporate associate in the Palo Alto office of Gibson Dunn. Hong is a member of the Life Sciences Group.
Hong advises companies on a broad range of capital markets transactions, securities law compliance and corporate governance issues with a focus on Life Sciences public companies. Hong also maintains an active pro bono practice.
Hong received their Juris Doctor degree in 2020 from Yale Law School, where they were an editor on the Yale Law Journal. Hong received their Bachelor of Arts degree from Yale College in 2014 where they were elected to Phi Beta Kappa. Hong was a 2017 Paul and Daisy Soros Fellow.
Hong is admitted to practice law in Texas and is a Specially Registered Attorney in California.
Representative Transactions:
- Catalyst Biosciences in its business combination transaction with Beijing Continent
- TuHURA Biosciences in its acquisition of Kineta
- Biodexa Pharmaceuticals PLC in its registered direct offering of American Depositary Shares
- GKCC in its purchase of senior secured convertible promissory note from Elicio Therapeutics
- CBI in its investment in Exicure’s PIPE offering
Publications:
- Comment Letter Trends: Contested Election Disclosures for the 2024 Proxy Season, Deal Lawyers, November-December 2024 Issue
- Comment Letter Trends: Contested Election Disclosures, Deal Lawyers, January-February 2024 Issue
Hong is admitted to practice law in Texas and permitted to practice law in California as a Registered Military Spouse Attorney.
Capabilities
Credentials
Education:
- Yale University - 2020 Juris Doctor
- Yale University - 2014 Bachelor of Arts
Admissions:
- Texas Bar